Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.725 USD | -1.99% | +6.36% | +210.62% |
05-09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
05-09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+210.62% | 323M | |
+30.09% | 684B | |
+30.34% | 568B | |
-3.93% | 361B | |
+18.10% | 329B | |
+4.16% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.81% | 166B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Goldman Sachs Downgrades Nektar Therapeutics to Sell from Neutral, Sets $3 Price Target